Search

Your search keyword '"Bristol-Myers Squibb Co. -- Forecasts and trends"' showing total 35 results
Start Over Descriptor "Bristol-Myers Squibb Co. -- Forecasts and trends" Publisher plus media solutions
35 results on '"Bristol-Myers Squibb Co. -- Forecasts and trends"'

1. Worldwide Biguanide Industry to 2026 - by Segments and Geography

Subjects
Merck & Company Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Metformin -- Reports -- Forecasts and trends, Type 2 diabetes -- Care and treatment, Diabetes therapy -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Biguanide Market 2020-2026' report has been added to ResearchAndMarkets.com's offering. The global biguanide market is forecast to grow at [...]

Published
2020

2. Global PD-L1 NSCLC Market: Insights, Epidemiology, Drugs and Players (2017-2030)

Subjects
United States. Food and Drug Administration -- Reports, Merck KGaA -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Durvalumab -- Reports -- Forecasts and trends, Ipilimumab -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Bevacizumab -- Reports -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has [...]

Published
2020

3. COVID-19 Impacts: Antiviral Drugs Market Will Accelerate at a CAGR of Over 9% Through 2020-2024 | Growing Cases of Viral Infections to Boost Growth | Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, GlaxoSmithKline PLC -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Antiviral agents -- Forecasts and trends -- Health aspects, Pharmaceutical industry -- Forecasts and trends, Biological products industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the antiviral drugs market and it is poised to grow by USD 43.37 billion during 2020-2024, progressing [...]

Published
2020

4. Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC) Market Insights and Forecasts, 2017-2030

Subjects
United States. Food and Drug Administration -- Reports, Merck KGaA -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Durvalumab -- Reports -- Forecasts and trends, Ipilimumab -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Bevacizumab -- Reports -- Forecasts and trends, Monoclonal antibodies -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Programmed Death-Ligand 1 (PD-L1) Non-Small Cell Lung Cancer (NSCLC)-Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has [...]

Published
2020

5. Castrate-resistant Prostate Cancer (CRPC): Market Insights, Epidemiology and Forecast to 2030

Subjects
United States. Food and Drug Administration -- Reports, Merck & Company Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Cabazitaxel -- Reports -- Forecasts and trends, Olaparib -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Prostate cancer -- Reports -- Forecasts and trends, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Antineoplastic agents -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Xtandi (Medication) -- Reports, Erleada (Medication) -- Reports, Lynparza (Medication) -- Reports, Nubeqa (Medication) -- Reports
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Castrate-resistant Prostate Cancer (CRPC) -Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's [...]

Published
2020

6. Pharmaceutical Pricing and Reimbursement 2020-2024 - Impact of COVID-19 on the Markets, Trends & Developments, Strategies, and Look to the Future

Subjects
Johnson & Johnson -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Vaccines -- Forecasts and trends, Pricing -- Forecasts and trends, Drugs -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Product price, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Pharmaceutical Pricing and Reimbursement: Global Markets' report has been added to ResearchAndMarkets.com's offering. During the first quarter of 2020, [...]

Published
2020

7. Global Pharmaceutical Pricing and Reimbursement Markets 2014-2024

Subjects
Johnson & Johnson -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Vaccines -- Forecasts and trends, Pricing -- Forecasts and trends, Drugs -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Product price, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Pharmaceutical Pricing and Reimbursement: Global Markets' report has been added to ResearchAndMarkets.com's offering. During the first quarter of 2020, [...]

Published
2020

8. Human Microbiome Therapeutics Market 2020-2024 | Growing Prevalence of Chronic Diseases to Boost Growth | Technavio

Subjects
Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Dow Inc. -- Forecasts and trends, Ferring Pharmaceuticals -- Forecasts and trends, Chronic diseases -- Reports -- Forecasts and trends, Chemical industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the human microbiome therapeutics market and it is poised to grow by USD 276.93 million during 2020-2024, [...]

Published
2020

9. Acute Lymphoblastic Leukemia Market is Expected to Grow with 4.8% CAGR During the Study Period of 2017-30 in 7 Major Markets

Subjects
Gilead Sciences Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Business research -- Reports -- Forecasts and trends, Ponatinib -- Reports -- Forecasts and trends, Cancer research -- Reports -- Forecasts and trends, Daratumumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Acute lymphocytic leukemia -- Forecasts and trends -- Reports, Biological products industry -- Forecasts and trends, Dasatinib -- Forecasts and trends -- Reports, Tisagenlecleucel -- Reports -- Forecasts and trends, T cells -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight has announced the expansion of the forecast period to 2020-2030 for its report on 'Acute Lymphoblastic Leukemia [...]

Published
2020

10. Leukemia Therapeutics Markets, 2015-2025 - Size by Value & Volume, Trends & Developments, Competitive Landscape

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Ionizing radiation -- Reports -- Forecasts and trends, Chemotherapy -- Reports -- Forecasts and trends, Leukemia -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Global Leukemia Therapeutics Market By Factor (Artificial ionizing radiation, Viruses, Chemotherapy, Genetics, Others), By Severity, By Blood Cell, By [...]

Published
2020

11. World Markets for Interferons, 2030 (COVID-19 Adjusted) - Roche, Merck, BMS, Biogen, Bayer, Zydus Cadila, Novartis, Pfizer, Biosidus, and Nanogen are the Major Players

Subjects
Merck & Company Inc. -- Forecasts and trends, Biogen Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Interferon -- Forecasts and trends, Biological products industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Interferons Global Market Report 2020-30: COVID-19 Implications and Growth' report has been added to ResearchAndMarkets.com's offering. This report covers [...]

Published
2020

12. Research Report with COVID-19 Forecasts - Human Microbiome Therapeutics Market 2020-2024 | Growing Prevalence of Chronic Diseases to Boost Growth | Technavio

Subjects
Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Dow Inc. -- Forecasts and trends, Ferring Pharmaceuticals -- Forecasts and trends, Chronic diseases -- Reports -- Forecasts and trends, Chemical industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Motor vehicle drivers, Diseases, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the human microbiome therapeutics market and it is poised to grow by USD 276.93 million during 2020-2024, [...]

Published
2020

13. Small Cell Lung Cancer (SCLC) Markets in the United States, EU5 and Japan (2017-2030): Epidemiology, Marketed & Emerging Drugs, Unmet Needs, Competitive Landscape

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Durvalumab -- Reports -- Forecasts and trends, BCG -- Forecasts and trends -- Reports, Atezolizumab -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Carboplatin -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Dinutuximab -- Reports -- Forecasts and trends, Drugs, Lung cancer, Market trend/market analysis, General interest, News, opinion and commentary, Tecentriq (Medication) -- Reports, Imfinzi (Medication) -- Reports
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Small Cell Lung Cancer (SCLC) - Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added [...]

Published
2020

14. Non-Small Cell Lung Cancer (NSCLC) Market Insights and Epidemiology 2017-2030

Subjects
Merck KGaA -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, Novartis Pharma AG -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Brigatinib -- Forecasts and trends -- Reports, Osimertinib -- Forecasts and trends -- Reports, Monoclonal antibodies -- Reports -- Forecasts and trends, Trametinib -- Reports -- Forecasts and trends, Romiplostim -- Reports -- Forecasts and trends, Pembrolizumab -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Non-small cell lung cancer -- Reports -- Forecasts and trends, Alectinib -- Forecasts and trends -- Reports, Durvalumab -- Reports -- Forecasts and trends, Dabrafenib -- Reports -- Forecasts and trends, Nivolumab -- Reports -- Forecasts and trends, Small cell lung cancer -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Avelumab, Necitumumab, Larotrectinib, Atezolizumab, Dacomitinib, Lorlatinib, Lung cancer, Profits, Market trend/market analysis, General interest, News, opinion and commentary, Opdivo (Medication) -- Reports, Keytruda (Medication) -- Reports, Tagrisso (Medication) -- Reports
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Non-Small Cell Lung Cancer (NSCLC) Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to [...]

Published
2020

15. Analysis on New Product Launches in Covid-19 Related Markets-Cancer Cachexia Therapeutics Market 2019-2023 | High Prevalence and Incidence Of Cancer Cachexia To Boost Growth | Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Hikma Pharmaceuticals PLC -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Mylan N.V. -- Forecasts and trends, Sun Pharmaceutical Industries Ltd. -- Forecasts and trends, ANI Pharmaceuticals Inc. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Fresenius SE & Company KGaA -- Forecasts and trends, Cancer -- Forecasts and trends -- Reports, Medical equipment industry -- Forecasts and trends, Cachexia -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Motor vehicle drivers, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the cancer cachexia therapeutics market and it is poised to grow by USD 568.85 mn during 2019-2023, [...]

Published
2020

16. Global Immune Checkpoint Inhibitors (ICI) Market Report 2020 Featuring FDA Approved Keytruda, Opdivo, Tecentriq, Imfinzi, Yervoy, Libtayo, and Bavencio

Subjects
Merck KGaA -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Durvalumab, Ipilimumab, Atezolizumab, Nivolumab, Avelumab, Pembrolizumab, Pharmaceutical industry -- Forecasts and trends, Drug approval, Accounting, Cemiplimab, Backup software, Market trend/market analysis, General interest, News, opinion and commentary, Opdivo (Medication), Keytruda (Medication)
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Immune Checkpoint Inhibitors Market' report has been added to ResearchAndMarkets.com's offering. Global immune checkpoint inhibitors market reached $22 billion [...]

Published
2020

17. Immune Checkpoint Inhibitors Markets, 2011-2019 & 2020-2025

Subjects
Merck KGaA -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Durvalumab, Ipilimumab, Atezolizumab, Nivolumab, Avelumab, Pembrolizumab, Pharmaceutical industry -- Forecasts and trends, Accounting, Cemiplimab, Backup software, Market trend/market analysis, General interest, News, opinion and commentary, Opdivo (Medication), Keytruda (Medication)
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Immune Checkpoint Inhibitors Market' report has been added to ResearchAndMarkets.com's offering. Global immune checkpoint inhibitors market reached $22 billion [...]

Published
2020

18. Global Immune Checkpoint Inhibitors Market Worth $40B by 2025 - Top Five Brands, Market Shares of Leading Companies, Sales Evolution, Future Outlook

Subjects
Merck KGaA -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Brand names, Durvalumab, Ipilimumab, Atezolizumab, Nivolumab, Stocks, Avelumab, Pembrolizumab, Pharmaceutical industry -- Forecasts and trends, Accounting, Cemiplimab, Backup software, Market trend/market analysis, General interest, News, opinion and commentary, Opdivo (Medication), Keytruda (Medication)
Abstract

Dublin: Research and Markets has issued the following news release: The 'Immune Checkpoint Inhibitors Market' report has been added to ResearchAndMarkets.com's offering. Global immune checkpoint inhibitors market reached $22 billion [...]

Published
2020

19. Global Cholangiocarcinoma Therapeutics Market 2019-2023 | Evolving Opportunities with Bristol-Myers Squibb Company and Eli Lilly and Company | Technavio

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Biliary tract cancer, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the global cholangiocarcinoma therapeutics market since 2018, and the market is poised to grow by USD 82.56 [...]

Published
2020

20. Global Colorectal Cancer Therapeutics Market 2019-2023 | Evolving Opportunities with Bristol-Myers Squibb Company and Eli Lilly and Company | Technavio

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Bevacizumab, Colorectal cancer, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Technavio Research has issued the following news release: Technavio has been monitoring the global colorectal cancer therapeutics market since 2015, and the market is poised to grow by USD [...]

Published
2020

21. Global Oncology Market Forecast 2023

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Motor vehicle drivers, Profits, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

New York: ReportLinker FR has issued the following press release: Reportlinker.com announces the release of the report 'Global Oncology Market Forecast 2023' - https://www.reportlinker.com/p05777316/?utm_source=GNW As per the research, global oncology [...]

Published
2020

22. Worldwide Insulin Markets, 2015-2018 & 2019-2025 - Key Players are Sanofi, Takeda, Novo Nordisk, Bristol-Myers Squibb, Novartis, Eli Lilly, Oramed, Dongbao Enterprise Group, and Biocon

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Novo Nordisk A/S -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Hypoglycemic agents, Pharmaceutical industry -- Forecasts and trends, Insulin detemir, Insulin lispro, Insulin glargine, Insulin glulisine, Retirement benefits, Insulin aspart, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Insulin Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2018-2025' report has been added to ResearchAndMarkets.com's offering. The global [...]

Published
2020

23. Global Cervical Cancer Drugs Market Report 2020: Market was Valued $15.3 Billion in 2018 and is Expected to Grow to $17.9 billion Through 2022

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Celgene Corp. -- Forecasts and trends, Cidofovir, Cervical cancer -- Drug therapy, Pharmaceutical industry -- Forecasts and trends, Antineoplastic agents, Drugs, Tumors, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Cervical Cancer Drugs Global Market Report 2020' report has been added to ResearchAndMarkets.com's offering. The global cervical cancer drugs [...]

Published
2019

24. Schizophrenia Drugs Markets, 2024 - Leading Players are Alkermes, Bristol-Myers Squibb, Eli Lilly & Company, Johnson & Johnson, and Allergan

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Allergan PLC -- Forecasts and trends, Drugs, Antipsychotic agents, Schizophrenia -- Drug therapy, Pharmaceutical industry -- Forecasts and trends, Psychotropic drugs, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Schizophrenia Drugs Market - Growth, Trends, and Forecast (2019-2024)' report has been added to ResearchAndMarkets.com's offering. The rise in [...]

Published
2019

25. Global Biopharmaceuticals Market Overview, 2018-2019 & Forecast to 2025

Subjects
Eli Lilly and Co. -- Forecasts and trends, Roche Holding AG -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, GlaxoSmithKline PLC -- Forecasts and trends, Merck & Company Inc. -- Forecasts and trends, Biogen Inc. -- Forecasts and trends, Chronic diseases, Biotechnology industries -- Forecasts and trends, Biopharmaceuticals, Pembrolizumab, Pharmaceutical industry -- Forecasts and trends, Pemetrexed, Biological products industry -- Forecasts and trends, Adalimumab, Dasatinib, Monoclonal antibodies, Antibodies, Biological products, Elderly, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Biopharmaceuticals - A Global Market Overview' report has been added to ResearchAndMarkets.com's offering. Global demand for Biopharmaceuticals by product [...]

Published
2019

26. Global Gastric Cancer Therapy Market (2019-2024): Major Players are F. Hoffmann-La Roche, Bristol-Myers Squibb, Pfizer, Merck & Co, and Celltrion

Subjects
F. Hoffmann-La Roche Ltd. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Merck & Company Inc. -- Forecasts and trends, Stomach cancer -- Health aspects, Cancer -- Health aspects, Chemotherapy -- Health aspects, Biotechnology industries -- Forecasts and trends -- Health aspects, Carboplatin -- Health aspects, Radiotherapy -- Health aspects, Pharmaceutical industry -- Forecasts and trends -- Health aspects, Cancer cells, Cancer treatment, Surgery, Radiation (Physics), Antineoplastic agents, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Gastric Cancer Therapy Market - Growth, Trends, and Forecast (2019 - 2024)' report has been added to ResearchAndMarkets.com's offering. [...]

Published
2019

27. Global $17.1Bn Leukemia Therapeutics Market Forecast to 2024: Focus on CLL, ALL, CML, AML

Subjects
Celgene Corp. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Blinatumomab, Chemotherapy, Pharmaceutical industry -- Forecasts and trends, Lymphocytic leukemia, Cancer treatment, Acute myelocytic leukemia, Chronic lymphocytic leukemia, Myeloid leukemia, Acute lymphocytic leukemia, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs), Mode of Administration (Oral, [...]

Published
2019

28. Global Immunotherapy Drugs Market to 2025: Market will Grow at a CAGR of 12.5% - Key Vendors are AbbVie, Amgen, F. Hoffmann-La Roche, Bristol-Myers Squibb, Johnson & Johnson, & Merck & Co

Subjects
F. Hoffmann-La Roche Ltd. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Johnson & Johnson -- Forecasts and trends, Merck & Company Inc. -- Forecasts and trends, Chronic diseases, Drugs, Biotechnology industries -- Forecasts and trends, Immunotherapy, Pharmaceutical industry -- Forecasts and trends, Motor vehicle drivers, Vendor relations, Novels, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Global Immunotherapy Drugs Market - Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025' report has been added to [...]

Published
2019

29. Anticoagulants Market, 2024 - Focus on Oral Anticoagulants & Injectable Anticoagulants (Unfractionated Heparin, & Low Molecular Weight Heparin)

Subjects
United States. Food and Drug Administration, Pfizer Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Bayer AG -- Forecasts and trends, Dalteparin, Anticoagulants, Pharmaceutical industry -- Forecasts and trends, Betrixaban, Idarucizumab, Dabigatran etexilate, Argatroban, Heparin, Rivaroxaban, Low molecular weight heparin, Fondaparinux, Apixaban, Bivalirudin, Market trend/market analysis, General interest, News, opinion and commentary, Xarelto (Medication)
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'Anticoagulants: Global Market Analysis, Trends, and Forecasts' report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive [...]

Published
2019

30. Global Orphan Drugs Market Report 2019-2024 Featuring Teva Pharmaceutical, Celgene, Merck & Co, Bristol-Myers Squibb, and F. Hoffmann-La Roche

Subjects
Celgene Corp. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Merck & Company Inc. -- Forecasts and trends, Orphan drugs, Pharmaceutical industry -- Forecasts and trends, Drugs, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Orphan Drugs Market - Growth, Trends, and Forecast (2019 - 2024)' report has been added to ResearchAndMarkets.com's offering. The [...]

Published
2019

31. Worldwide Anti-infective Agents Market Outlook 2019-2026 - Led by Abbott, Gilead Sciences, Bristol-Myers Squibb, Merck & Co, Bayer, AstraZeneca, Boehringer Ingelheim, and Novartis

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Bayer AG -- Forecasts and trends, Novartis AG -- Forecasts and trends, Merck & Company Inc. -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Biological products industry -- Forecasts and trends, Antifungal agents, Antiviral agents, Communicable diseases, Antibacterial agents, Anti-HIV agents, Cobicistat, Ebola virus, Distribution channels, Elvitegravir, HIV, Emtricitabine, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Anti-infective Agents Market Size, Share & Trend Analysis By Type (Antibacterial, Antifungal, Antiviral), By Route of Administration (Oral, Topical, [...]

Published
2019

32. Acute Heart Failure Therapeutics Market Checkout The Unexpected Future 2026

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Heart failure, Natriuretic peptides, Heart, Peptides, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

SEATTLE: Coherent Market Insights has issued the following news release: Acute heart failure (AHF) is a progressive condition, in which, the heart muscle is unable to pump enough blood through [...]

Published
2019

33. Blood Preparation Market to hit $78.5 Billion by 2025: Global Market Insights, Inc

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Anticoagulants, Thrombophlebitis, Thrombosis, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

UNITED STATES: Global Market Insights, Inc has issued the following press release: Anti-thrombotic and anticoagulants segment of blood preparation market is estimated to grow significantly over the analysis period to [...]

Published
2019

34. Biopharma in 2018: Vantage Releases Annual Analysis of Pharma, Biotech and Medtech Performance

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Biological products industry -- Forecasts and trends, Biotechnology, Financial markets, Stock prices, Product licensing, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LONDON: Vantage has issued the following press release: Macroeconomic trends in Q4 wiped out biopharma's stock market gains from earlier in 2018, with the S&P Pharmaceuticals Index the only major [...]

Published
2019

35. Global Human Immunodeficiency Virus (HIV) Drugs Market 2019-2025 with AbbVie, Merck, Gilead Sciences, Bristol-Myers Squibb, Janssen & GSK Dominating

Subjects
Merck & Company Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, HIV -- Drug therapy, Drugs, Biological products industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 - 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts' [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results